血清miR-92a-3p、SIRT6对胸段食管癌患者术后复发的预测价值OA
Predictive value of serum miR-92a-3p and SIRT6 for post-operative recurrence in patients with thoracic esophageal cancer
目的 探讨血清微小RNA(miRNA)-92a-3p、沉默信息调节因子6(SIRT6)对胸段食管癌患者术后复发的预测价值.方法 选取2021年1月至2024年3月该院收治的接受根治性手术的95例胸段食管癌患者作为研究组.另选取同期在该院体检的108例无既往肿瘤史的健康志愿者作为对照组.采用医院自制统计表收集所有受试者入院时基线资料.对所有胸段食管癌患者采用术后定期门诊复查的方式进行为期6个月的随访,并根据随访结果,将其分为复发组和非复发组.采用实时荧光定量聚合酶链反应检测血清 miR-92a-3p表达水平,采用酶联免疫吸附试验检测血清SIRT6表达水平.采用Pearson相关分析胸段食管癌患者血清miR-92a-3p表达水平与血清SIRT6表达水平的相关性.绘制受试者工作特征(ROC)曲线分析血清 miR-92a-3p、SIRT6单独及联合预测胸段食管癌患者术后复发的价值.结果 与对照组相比,研究组血清 miR-92a-3p表达水平升高,血清SIRT6表达水平降低,差异均有统计学意义(P<0.05).miR-92a-3p与SIRT6存在潜在结合位点,且二者表达水平呈负相关(r=-0.631,P<0.001).胸段食管癌患者血清 miR-92a-3p、SIRT6不同表达水平患者N分期、TNM 分期比较,差异均有统计学意义(P<0.05).随访结果显示,复发组26例,非复发组69例.与非复发组相比,复发组血清 miR-92a-3p表达水平升高,血清SIRT6表达水平降低,差异均有统计学意义(P<0.05).ROC曲线分析结果显示,血清 miR-92a-3p、SIRT6单独及联合预测胸段食管癌患者术后复发的曲线下 面 积(AUC)分别为0.881、0.867、0.971,二者联合预测的 AUC明显大于 miR-92a-3p(Z=2.417,P=0.015)、SIRT6(Z=2.327,P=0.035)单独预测的AUC.结论 胸段食管癌术后复发患者血清 miR-92a-3p表达水平升高,血清SIRT6表达水平降低,且二者联合对胸段食管癌患者术后复发具有较高预测价值.
Objective To explore the predictive value of serum microRNA(miRNA)-92a-3p and silent in-formation regulator 6(SIRT6)expression levels for post-operative recurrence in patients with thoracic esoph-ageal cancer.Methods A total of 95 patients with thoracic esophageal cancer who underwent radical surgery in the hospital from January 2021 to March 2024 were selected as the study group.Meanwhile,108 healthy volunteers without a history of cancer who had physical examinations in the hospital during the same period were selected as the control group.Baseline data of all subjects on admission were collected by self-made sta-tistical form of the hospital.All patients with thoracic esophageal cancer were followed up for 6 months through regular outpatient reviews after surgery.According to the follow-up results,they were divided into re-currence group and non-recurrence group.The expression level of serum miR-92a-3p was detected by real-time fluorescence quantitative polymerase chain reaction,and the expression level of serum SIRT6 was detected by enzyme-linked immunosorbent assay.Pearson correlation was used to analyze the correlation between serum miR-92a-3p expression level and serum SIRT6 expression level in patients with thoracic esophageal cancer.The receiver operating characteristic(ROC)curve was plotted to analyze the value of serum miR-92a-3p,SIRT6 alone and in combination for predicting post-operative recurrence in patients with thoracic esophageal cancer.Results Compared with the control group,the expression level of serum miR-92a-3p in the study group was higher,and the expression level of serum SIRT6 was lower,with statistically significant differences(P<0.05).There were potential binding sites between miR-92a-3p and SIRT6,and their expression levels were negatively correlated(r=—0.631,P<0.001).In patients with thoracic esophageal cancer,there were statistically significant differences in N stage and TNM stage between patients with different expression levels of serum miR-92a-3p and SIRT6(P<0.05).Following-up results showed that there were 26 patients in the recurrence group and 69 in the non-recurrence group.Compared with the non-recurrence group,the expression level of serum miR-92a-3p in the recurrence group was higher,and the expression level of serum SIRT6 was lower,with statistically significant differences(P<0.05).The results of ROC curve analysis showed that the areas under the curves(AUCs)of serum miR-92a-3p,SIRT6 alone and in combination for predicting post-op-erative recurrence in patients with thoracic esophageal cancer were 0.881,0.867 and 0.971 respectively.The AUC of the combined prediction of the both indicators was significantly larger than that of miR-92a-3p alone(Z=2.417,P=0.015)and SIRT6 alone(Z=2.327,P=0.035).Conclusion The serum miR-92a-3p expres-sion level is high and serum SIRT6 expression level is low in patients with recurrent thoracic esophageal canc-er after surgery,and the combination of the two indicators has a high predictive value for post-operative recur-rence in patients with thoracic esophageal cancer.
刘洋;程鹏涛;王艳汝;李辉
淄博一四八医院心胸外科,山东 淄博 255300淄博一四八医院心胸外科,山东 淄博 255300淄博一四八医院肿瘤实验室,山东 淄博 255300淄博一四八医院心胸外科,山东 淄博 255300
医药卫生
胸段食管癌微小RNA-92a-3p沉默信息调节因子6复发预测
thoracic esophageal cancermiR-92a-3psilent information regulator 6recurrenceprediction
《检验医学与临床》 2026 (8)
1070-1075,1082,7
中国管理科学研究院教育科学研究所科教创新研究重点课题(KJCX10742).
评论